WithdrawnNCT00257361
D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for OCD
Medication studyAges 18–65
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2005
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of Florida
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00257361
- Official title
Show the full official title
D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
Recruitment & locations
WithdrawnLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is University of Florida, a university.
Does this study involve medication?
Yes. The study involves medication, including D-Cycloserine.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
